V
10.63
0.38 (3.71%)
| Previous Close | 10.25 |
| Open | 10.32 |
| Volume | 1,618,106 |
| Avg. Volume (3M) | 2,388,651 |
| Market Cap | 800,649,472 |
| Price / Sales | 44.31 |
| Price / Book | 15.35 |
| 52 Weeks Range | |
| Earnings Date | 4 Nov 2025 |
| Operating Margin (TTM) | -1,310.71% |
| Diluted EPS (TTM) | -3.36 |
| Total Debt/Equity (MRQ) | 128.59% |
| Current Ratio (MRQ) | 3.50 |
| Operating Cash Flow (TTM) | -115.14 M |
| Levered Free Cash Flow (TTM) | -67.89 M |
| Return on Assets (TTM) | -64.19% |
| Return on Equity (TTM) | -2,159.52% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Biotechnology (US) | Bullish | Mixed |
| Biotechnology (Global) | Bullish | Mixed | |
| Stock | Verastem, Inc. | Bullish | Bullish |
AIStockmoo Score
-1.1
| Analyst Consensus | 1.5 |
| Insider Activity | -5.0 |
| Price Volatility | -5.0 |
| Technical Moving Averages | -1.0 |
| Technical Oscillators | 4.0 |
| Average | -1.10 |
|
Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer. Its pipeline is focused on novel anticancer agents that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, particularly RAF/MEK inhibition and FAK inhibition. |
|
| Sector | Healthcare |
| Industry | Biotechnology |
| Investment Style | Small Core |
| % Held by Insiders | 0.93% |
| % Held by Institutions | 78.87% |
| 52 Weeks Range | ||
| Median | 20.00 (88.15%) | |
| Total | 1 Buy | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| BTIG | 09 Sep 2025 | 20.00 (88.15%) | Buy | 9.92 |
| Name | Avg. Buy ($) | Avg. Sell ($) | Net Quantity | Net Value ($) |
|---|---|---|---|---|
| PATERSON DAN | - | 10.27 | -16,000 | -164,280 |
| Aggregate Net Quantity | -16,000 | |||
| Aggregate Net Value ($) | -164,280 | |||
| Aggregate Avg. Buy ($) | - | |||
| Aggregate Avg. Sell ($) | 10.27 | |||
| Name | Holder | Date | Type | Quantity | Price | Value ($) |
|---|---|---|---|---|---|---|
| PATERSON DAN | Officer | 04 Dec 2025 | Automatic sell (-) | 2,000 | 10.60 | 21,200 |
| PATERSON DAN | Officer | 03 Dec 2025 | Automatic sell (-) | 2,000 | 10.06 | 20,120 |
| PATERSON DAN | Officer | 02 Dec 2025 | Automatic sell (-) | 2,000 | 9.78 | 19,560 |
| PATERSON DAN | Officer | 01 Dec 2025 | Automatic sell (-) | 2,000 | 10.34 | 20,680 |
| PATERSON DAN | Officer | 28 Nov 2025 | Automatic sell (-) | 2,000 | 10.64 | 21,280 |
| PATERSON DAN | Officer | 26 Nov 2025 | Automatic sell (-) | 2,000 | 10.63 | 21,260 |
| PATERSON DAN | Officer | 25 Nov 2025 | Automatic sell (-) | 2,000 | 10.25 | 20,500 |
| PATERSON DAN | Officer | 24 Nov 2025 | Automatic sell (-) | 2,000 | 9.84 | 19,680 |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |